Trust Size
$12M
What Happened
Eucrates Biomedical Acquisition Corp. filed its S-1 registration in 2020. The company was delisted from exchanges with 74 SEC filings on record.
Eucrates Biomedical Acquisition Corp. entered the SPAC market in 2020 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
SEC records show 74 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2023-05-08, and it appears to have been delisted from exchanges â a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
The company was incorporated in D8.
Timeline
2020-10-21
S-1 Registration Filed
2023-05-08
Last SEC Filing
SEC Filing Details
CIK Number
1822929
Total SEC Filings
74
State of Incorporation
D8
Last Filing Date
2023-05-08
Business Location
New York, NY
Trust/Asset Size
$12M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Eucrates Biomedical Acquisition